rethinkTHC Search
Menu
Study breakdown

CBD significantly reduced abnormal brain electrical activity and improved sleep in children with epilepsy

Prospective CohortModerate evidence
The takeaway

In 35 children with drug-resistant epilepsy, CBD reduced interictal epileptiform discharges by nearly half and improved sleep microstructure in 85% of those with abnormal sleep patterns.

Pediatric neurologists, families of children with drug-resistant epilepsy.

IED rate dropped from 36.8 to 19.6 per minute after 3 months of CBD

What the researchers found

Interictal epileptiform discharge (IED) rate dropped significantly from 36.8 to 19.6 per minute after 3 months of CBD (p<0.0001). IED reduction moderately correlated with seizure reduction (r=0.39, p=0.02). Sleep microstructure was initially abnormal in 56.5% of recorded cases and improved in 84.6% of those. Higher initial IED rates predicted greater reduction.

Why it matters

Beyond reducing seizures, CBD appears to address the underlying electrical abnormalities between seizures and improve sleep quality. These effects could contribute to better cognitive function and quality of life in children with epilepsy.

The numbers in context

35 children, mean age 10.1. IED rate: 36.8 baseline to 19.6 at 3 months (p<0.0001). IED-seizure correlation: r=0.39 (p=0.02). Abnormal sleep: 56.5%. Sleep improvement in abnormal group: 84.6%. CBD dose: 20-50 mg/kg/day.

How the study worked

Prospective open-label trial of 35 children (mean age 10.1) with drug-resistant epilepsy. CBD at 20 mg/kg/day (up to 50 mg/kg/day) with stable concomitant medications. EEGs recorded at baseline and 3 months. Two blinded independent raters evaluated IED rates in sleep stage 2 or awake state.

What this study cannot tell us

Open-label design with no placebo group. Small sample. Only 3 months of follow-up. Subjective visual IED counting. Cannot separate CBD effects from natural disease fluctuation.

How to read the evidence

Prospective design with blinded EEG raters strengthens findings, but open-label and small sample are limitations.

When this study was published

2021 prospective open-label trial from Germany.

The bigger picture

Most epilepsy drug studies focus only on seizure counts. This study reveals that CBD may have broader brain effects, reducing abnormal electrical activity and improving sleep architecture, both of which are important for overall brain health in developing children.

Questions still open

  • Does IED reduction predict long-term seizure outcomes? Would the sleep improvement translate to measurable cognitive gains? Do these effects persist beyond 3 months?

Common questions

Does CBD reduce abnormal brain activity between seizures?
Yes. In this study, CBD cut interictal epileptiform discharges nearly in half (from 36.8 to 19.6 per minute) after 3 months, and this reduction correlated with seizure reduction.
Did CBD improve sleep in these children?
Yes. Among children with initially abnormal sleep patterns (56.5% of those recorded), 84.6% showed improved sleep microstructure after 3 months of CBD.

Read the original research

Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study.

CNS drugs, 35(11), 1207-1215

Citation

Klotz, Kerstin A; Grob, Daniel; Schönberger, Jan; Nakamura, Lea; Metternich, Birgitta; Schulze-Bonhage, Andreas; Jacobs, Julia. (2021). Effect of Cannabidiol on Interictal Epileptiform Activity and Sleep Architecture in Children with Intractable Epilepsy: A Prospective Open-Label Study.. CNS drugs, 35(11), 1207-1215. https://doi.org/10.1007/s40263-021-00867-0

Explore the wider topic